These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 29906461)

  • 1. Sphingomyelin phosphodiesterase 1 (SMPD1) mediates the attenuation of myocardial infarction-induced cardiac fibrosis by astaxanthin.
    Shi Y; Lin P; Wang X; Zou G; Li K
    Biochem Biophys Res Commun; 2018 Sep; 503(2):637-643. PubMed ID: 29906461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Astaxanthin promotes M2 macrophages and attenuates cardiac remodeling after myocardial infarction by suppression inflammation in rats.
    Pan X; Zhang K; Shen C; Wang X; Wang L; Huang YY
    Chin Med J (Engl); 2020 Aug; 133(15):1786-1797. PubMed ID: 32701588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Notch3 Ameliorates Cardiac Fibrosis After Myocardial Infarction by Inhibiting the TGF-β1/Smad3 Pathway.
    Zhang M; Pan X; Zou Q; Xia Y; Chen J; Hao Q; Wang H; Sun D
    Cardiovasc Toxicol; 2016 Oct; 16(4):316-24. PubMed ID: 26487518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caffeic acid mitigates myocardial fibrosis and improves heart function in post-myocardial infarction by inhibiting transforming growth factor-β receptor 1 signaling pathways.
    Jiang W; Deng B; Xie M; Feng Y; Jiang X; Yang B; Tan Z; Ou H; Tan Y; Liu S; Zhang S; Zhang J; Zhou Y; Wu W; Liu B
    Biomed Pharmacother; 2024 Aug; 177():117012. PubMed ID: 38906025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel mechanism of cardiac protection by valsartan: synergetic roles of TGF-β1 and HIF-1α in Ang II-mediated fibrosis after myocardial infarction.
    Sui X; Wei H; Wang D
    J Cell Mol Med; 2015 Aug; 19(8):1773-82. PubMed ID: 25823960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced postmyocardial infarction fibrosis via stimulation of the transforming growth factor-beta-Smad2 signaling pathway: role of transient receptor potential vanilloid type 1 channels.
    Huang W; Rubinstein J; Prieto AR; Wang DH
    J Hypertens; 2010 Feb; 28(2):367-76. PubMed ID: 19887954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calycosin reduces myocardial fibrosis and improves cardiac function in post-myocardial infarction mice by suppressing TGFBR1 signaling pathways.
    Chen G; Xu H; Xu T; Ding W; Zhang G; Hua Y; Wu Y; Han X; Xie L; Liu B; Zhou Y
    Phytomedicine; 2022 Sep; 104():154277. PubMed ID: 35752078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liraglutide improves myocardial fibrosis after myocardial infarction through inhibition of CTGF by activating cAMP in mice.
    Huang DD; Huang HF; Yang Q; Chen XQ
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4648-4656. PubMed ID: 30058704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Qiliqiangxin improves cardiac function and attenuates cardiac remodeling in rats with experimental myocardial infarction.
    Wang J; Zhou J; Ding X; Zhu L; Jiang K; Fu M; Wang S; Hu K; Ge J
    Int J Clin Exp Pathol; 2015; 8(6):6596-606. PubMed ID: 26261541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impairment of cardiac function and remodeling induced by myocardial infarction in rats are attenuated by the nonpeptide angiotensin-(1-7) analog AVE 0991.
    Zeng WT; Chen WY; Leng XY; Tang LL; Sun XT; Li CL; Dai G
    Cardiovasc Ther; 2012 Jun; 30(3):152-61. PubMed ID: 21167013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DPP-4 inhibition has beneficial effects on the heart after myocardial infarction.
    Kubota A; Takano H; Wang H; Hasegawa H; Tadokoro H; Hirose M; Kobara Y; Yamada-Inagawa T; Komuro I; Kobayashi Y
    J Mol Cell Cardiol; 2016 Feb; 91():72-80. PubMed ID: 26739213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Rho-kinase ameliorates myocardial remodeling and fibrosis in pressure overload and myocardial infarction: role of TGF-β1-TAK1.
    Li Q; Xu Y; Li X; Guo Y; Liu G
    Toxicol Lett; 2012 Jun; 211(2):91-7. PubMed ID: 22465603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-infarct treatment with [Pyr(1)]apelin-13 improves myocardial function by increasing neovascularization and overexpression of angiogenic growth factors in rats.
    Azizi Y; Faghihi M; Imani A; Roghani M; Zekri A; Mobasheri MB; Rastgar T; Moghimian M
    Eur J Pharmacol; 2015 Aug; 761():101-8. PubMed ID: 25936512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astaxanthin attenuated pressure overload-induced cardiac dysfunction and myocardial fibrosis: Partially by activating SIRT1.
    Zhang J; Wang QZ; Zhao SH; Ji X; Qiu J; Wang J; Zhou Y; Cai Q; Zhang J; Gao HQ
    Biochim Biophys Acta Gen Subj; 2017 Jul; 1861(7):1715-1728. PubMed ID: 28300638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cardioprotective effect of astaxanthin against isoprenaline-induced myocardial injury in rats: involvement of TLR4/NF-κB signaling pathway.
    Zaafan MA; Abdelhamid AM
    Eur Rev Med Pharmacol Sci; 2021 Jun; 25(11):4099-4105. PubMed ID: 34156689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. α1A Adrenoreceptor blockade attenuates myocardial infarction by modulating the integrin-linked kinase/TGF-β/Smad signaling pathways.
    Alrasheed NM; Alammari RB; Alshammari TK; Alamin MA; Alharbi AO; Alonazi AS; Bin Dayel AF; Alrasheed NM
    BMC Cardiovasc Disord; 2023 Mar; 23(1):153. PubMed ID: 36964489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dipeptidyl peptidase 4 inhibitor attenuates obesity-induced myocardial fibrosis by inhibiting transforming growth factor-βl and Smad2/3 pathways in high-fat diet-induced obesity rat model.
    Hong SK; Choo EH; Ihm SH; Chang K; Seung KB
    Metabolism; 2017 Nov; 76():42-55. PubMed ID: 28987239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac fibrogenesis following infarction in mice with deletion of inducible nitric oxide synthase.
    Lu L; Chen SS; Hassid A; Sun Y
    Am J Med Sci; 2008 Jun; 335(6):431-8. PubMed ID: 18552572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyridostigmine ameliorates cardiac remodeling induced by myocardial infarction via inhibition of the transforming growth factor-β1/TGF-β1-activated kinase pathway.
    Lu Y; Liu JJ; Bi XY; Yu XJ; Kong SS; Qin FF; Zhou J; Zang WJ
    J Cardiovasc Pharmacol; 2014 May; 63(5):412-20. PubMed ID: 24805145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic urocortin 2 administration improves cardiac function and ameliorates cardiac remodeling after experimental myocardial infarction.
    Ellmers LJ; Scott NJ; Cameron VA; Richards AM; Rademaker MT
    J Cardiovasc Pharmacol; 2015 Mar; 65(3):269-75. PubMed ID: 25658462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.